Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HWH486 in Chronic Spontaneous Urticaria
NCT06295302Phase 2Recruiting
- Sponsor
- Hubei Bio-Pharmaceutical Industrial Technological Institute
- Start
- Dec 2023
- Primary completion
- Dec 2025
- Modality
- Drug Delivery Systems
- Countries
- 1
01
Overview
A Phase 2 trial of HWH486 in chronic spontaneous urticaria (CSU), sponsored by Hubei Bio-Pharmaceutical Industrial Technological Institute. Started Dec 2023; status: recruiting.
02
Drugs
HWH486
03
Conditions
chronic spontaneous urticaria (CSU)
Beyond the preview
Go deeper on NCT06295302.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06295302.